{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:24:50Z","timestamp":1791822290307,"version":"4.3.4"},"reference-count":152,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EU NextGenerationEU through the Recovery and Resilience Plan for Slovakia","award":["09I03-03-V04-00427"],"award-info":[{"award-number":["09I03-03-V04-00427"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Dimethyl fumarate (DMF) has established a significant position among therapies for multiple sclerosis and psoriasis and is now being investigated for repurposing to many other non-malignant diseases. Despite decades of preclinical research, some issues about its pharmacology remain unresolved, with ongoing debate over which of the methyl esters of fumarate, whether DMF or monomethyl fumarate (MMF), is the active ingredient. It is generally accepted that DMF undergoes enzymatic hydrolysis to MMF and methanol. However, there is disagreement regarding its exact site, its extent, and the responsible enzyme(s). The enzymatic mechanisms, particularly the roles of carboxylesterases-1 and 2, vary across tissues and species, complicating the translation of in vitro and in vivo preclinical findings into clinical practice. In addition, the impact of DMF and MMF is often not clearly distinguishable and sometimes overlaps, making the true molecular mediators of therapeutic and side effects unclear. Thus, the interpretation of some results obtained in studies is inconsistent because of interchanging of in vitro and in vivo observed features of fumarate esters: while DMF demonstrates rapid and strong effects in cell culture studies, including nuclear factor erythroid 2-related factor 2 (NRF2) function activation and glutathione depletion, these observations may not exactly reflect systemic pharmacology and physiology dominated by MMF. Moreover, methanol, the co-product of DMF metabolism, may contribute to the observed DMF effects through increased production of reactive oxygen species, which could result in activation of NRF2-dependent mechanisms. This review highlights specific unresolved issues in DMF metabolism, which are sometimes overlooked.<\/jats:p>","DOI":"10.3390\/pharmaceutics17121506","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T09:02:07Z","timestamp":1763974927000},"page":"1506","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dimethyl Fumarate vs. Monomethyl Fumarate: Unresolved Pharmacologic Issues"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-0724","authenticated-orcid":false,"given":"Jana","family":"Kopincova","sequence":"first","affiliation":[{"name":"Centre of Experimental Medicine, Slovak Academy of Sciences, Institute of Normal and Pathological Physiology, 813 71 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6120-706X","authenticated-orcid":false,"given":"Iveta","family":"Bernatova","sequence":"additional","affiliation":[{"name":"Centre of Experimental Medicine, Slovak Academy of Sciences, Institute of Normal and Pathological Physiology, 813 71 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Paolinelli, M., Diotallevi, F., Emanuela, M., Giulia, R., Tommaso, B., Alfredo, G., Anna, C., and Annamaria, O. (2022). New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122732"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bresciani, G., Manai, F., Davinelli, S., Tucci, P., Saso, L., and Amadio, M. (2023). Novel Potential Pharmacological Applications of Dimethyl Fumarate\u2014An Overview and Update. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1264842"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Oliveira, A.P.d., Figueiredo-Junior, A.T., Mineiro, P.C.d.O., Mota, E.C., Amorim, C.S.d., Valenca, H.d.M., Gomes, A.C.C.d.A., Serra, S.S.d.S., Silva, P.L., and Takiya, C.M. (2025). Modulation of Pulmonary Inflammation and the Redox Pathway In Vitro and In Vivo by Fumaric Ester. Antioxidants, 14.","DOI":"10.3390\/antiox14091141"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s12265-025-10695-y","article-title":"Fumarate Signaling in Cardiovascular Disease: Therapeutic Potential and Pathologic Pitfalls of DMF\/MMF and FH1 Deficiency","volume":"18","author":"Zheng","year":"2025","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"108395","DOI":"10.1016\/j.intimp.2021.108395","article-title":"Dimethyl Fumarate Attenuates LPS Induced Septic Acute Kidney Injury by Suppression of NF\u03baB P65 Phosphorylation and Macrophage Activation","volume":"102","author":"Tang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"28017","DOI":"10.1074\/jbc.M112.383380","article-title":"Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor \u03baB (NF-\u03baB) and Extracellular Signal-Regulated Kinase 1 and 2 (ERK1\/2) and Mitogen Stress-Activated Kinase 1 (MSK1) Signaling","volume":"287","author":"Peng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Fern\u00e1ndez, M., Su\u00e1rez-Rojas, I., Bai, X., Mart\u00ednez-Martel, I., Ciaffaglione, V., Pittal\u00e0, V., Salerno, L., and Pol, O. (2023). Novel Heme Oxygenase-1 Inducers Palliate Inflammatory Pain and Emotional Disorders by Regulating NLRP3 Inflammasome and Activating the Antioxidant Pathway. Antioxidants, 12.","DOI":"10.3390\/antiox12101794"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tastan, B., Arioz, B.I., Tufekci, K.U., Tarakcioglu, E., Gonul, C.P., Genc, K., and Genc, S. (2021). Dimethyl Fumarate Alleviates NLRP3 Inflammasome Activation in Microglia and Sickness Behavior in LPS-Challenged Mice. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.737065"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113781","DOI":"10.1016\/j.yexcr.2023.113781","article-title":"Dimethyl Fumarate Attenuates Cholestatic Liver Injury by Activating the NRF2 and FXR Pathways and Suppressing NLRP3\/GSDMD Signaling in Mice","volume":"432","author":"Xu","year":"2023","journal-title":"Exp. Cell Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115166","DOI":"10.1016\/j.fct.2024.115166","article-title":"Molecular Insights of T-2 Toxin Exposure-Induced Neurotoxicity and the Neuroprotective Effect of Dimethyl Fumarate","volume":"196","author":"Pei","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e98970","DOI":"10.7554\/eLife.98970","article-title":"Diet Modulates the Therapeutic Effects of Dimethyl Fumarate Mediated by the Immunometabolic Neutrophil Receptor HCAR2","volume":"14","author":"Kosinska","year":"2025","journal-title":"eLife"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2025.03.008","article-title":"Dimethyl Fumarate for Pediatric-Onset Multiple Sclerosis: A Systematic Review","volume":"167","author":"Etemadifar","year":"2025","journal-title":"Pediatr. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rosito, M., Testi, C., Parisi, G., Cortese, B., Baiocco, P., and Di Angelantonio, S. (2020). Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment. Antioxidants, 9.","DOI":"10.3390\/antiox9080700"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Manai, F., Zanoletti, L., Arfini, D., Micco, S.G.D., Gjyzeli, A., Comincini, S., and Amadio, M. (2023). Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut Disorders. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24129912"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mills, E.A., Ogrodnik, M.A., Plave, A., and Mao-Draayer, Y. (2018). Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00005"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2008.08.041","article-title":"The Psoriasis Drug Monomethylfumarate Is a Potent Nicotinic Acid Receptor Agonist","volume":"375","author":"Tang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2012.06.003","article-title":"Role of HCA2 (GPR109A) in Nicotinic Acid and Fumaric Acid Ester-Induced Effects on the Skin","volume":"136","author":"Hanson","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Parodi, B., Sanna, A., Cedola, A., Uccelli, A., and Kerlero de Rosbo, N. (2021). Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.655212"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tips.2021.01.004","article-title":"Emerging Therapeutic Applications for Fumarates","volume":"42","author":"Hoogendoorn","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_20","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research (2025, August 13). Clinical Pharmacology and Biopharmaceutics Review(s), Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/204063Orig1s000ClinPharmR.pdf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4155\/ppa.14.9","article-title":"Tecfidera\u00ae: An Approach for Repurposing","volume":"3","author":"Spencer","year":"2014","journal-title":"Pharm. Pat. Anal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00403-013-1332-y","article-title":"Detection of Fumarate\u2013Glutathione Adducts in the Portal Vein Blood of Rats: Evidence for Rapid Dimethylfumarate Metabolism","volume":"305","author":"Dibbert","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdd.364","article-title":"Presystemic Metabolism and Intestinal Absorption of Antipsoriatic Fumaric Acid Esters","volume":"24","author":"Werdenberg","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yang, B., Parker, R.B., Meibohm, B., Temrikar, Z.H., Srivastava, A., and Laizure, S.C. (2022). Alcohol Inhibits the Metabolism of Dimethyl Fumarate to the Active Metabolite Responsible for Decreasing Relapse Frequency in the Treatment of Multiple Sclerosis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0278111"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.clinthera.2013.08.009","article-title":"Tolerability and Pharmacokinetics of Delayed-Release Dimethyl Fumarate Administered With and Without Aspirin in Healthy Volunteers","volume":"35","author":"Sheikh","year":"2013","journal-title":"Clin. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"rs10","DOI":"10.1126\/scisignal.aaf7694","article-title":"Chemical Proteomic Map of Dimethyl Fumarate\u2013Sensitive Cysteines in Primary Human T Cells","volume":"9","author":"Blewett","year":"2016","journal-title":"Sci. Signal."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Tang, J., Zhou, Y., Xiao, Q., Chen, Q., Wang, H., Lan, J., Wu, L., and Peng, Y. (2023). Short-Term Exposure to Dimethyl Fumarate (DMF) Inhibits LPS-Induced I\u03baB\u03b6 Expression in Macrophages. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1114897"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/je100964a","article-title":"Solubility of Dimethyl Fumarate in Methanol, Ethanol, 1-Propanol, 2-Propanol, 1,2-Propanediol, and Water from (289.95 to 347.15) K","volume":"56","author":"Wang","year":"2011","journal-title":"J. Chem. Eng. Data"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Litjens, N.H., Van Strijen, E., Van Gulpen, C., Mattie, H., Van Dissel, J.T., Thio, H.B., and Nibbering, P.H. (2004). In Vitro Pharmacokinetics of Anti-Psoriatic Fumaric Acid Esters. BMC Pharmacol., 4.","DOI":"10.1186\/1471-2210-4-22"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107617","DOI":"10.1016\/j.jddst.2025.107617","article-title":"Intranasal Delivery of Dimethyl Fumarate and Monomethyl Fumarate Using Hyaluronic Acid-Based Hybrid Nanoparticles to Enhance CNS Bioavailability","volume":"114","author":"Serri","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00498254.2019.1678078","article-title":"Is Genetic Variability in Carboxylesterase-1 and Carboxylesterase-2 Drug Metabolism an Important Component of Personalized Medicine?","volume":"50","author":"Laizure","year":"2020","journal-title":"Xenobiotica"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2006.03.005","article-title":"S-(2-Succinyl)Cysteine: A Novel Chemical Modification of Tissue Proteins by a Krebs Cycle Intermediate","volume":"450","author":"Alderson","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1038\/s41467-018-06787-w","article-title":"Dimethyl Fumarate Is an Allosteric Covalent Inhibitor of the P90 Ribosomal S6 Kinases","volume":"9","author":"Andersen","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.03.040","article-title":"Kinetic Assessment of Michael Addition Reactions of Alpha, Beta-Unsaturated Carbonyl Compounds to Amino Acid and Protein Thiols","volume":"169","author":"Sauerland","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_35","first-page":"1315","article-title":"Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy","volume":"70","author":"Gold","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1007\/s12325-019-01085-3","article-title":"Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study","volume":"36","author":"Palte","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bmc.2006.09.053","article-title":"Reactivity of Dimethyl Fumarate and Methylhydrogen Fumarate towards Glutathione and N-Acetyl-l-Cysteine\u2014Preparation of S-Substituted Thiosuccinic Acid Esters","volume":"15","author":"Schmidt","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_38","unstructured":"European Medicines Agency (2022). Tecfidera, INN-Dimethyl Fumarate, EMA. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/tecfidera-epar-public-assessment-report_en.pdf."},{"key":"ref_39","unstructured":"(2025, November 17). Angene Safety Data Sheet Monomethyl Fumarate. Available online: https:\/\/angenechemical.com\/sds\/2756-87-8.pdf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.tem.2025.03.008","article-title":"Fumarate Integrates Metabolism and Immunity in Diseases","volume":"36","author":"Cheng","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF03401897","article-title":"Parallel Induction of Heme Oxygenase-1 and Chemoprotective Phase 2 Enzymes by Electrophiles and Antioxidants: Regulation by Upstream Antioxidant-Responsive Elements (ARE)","volume":"1","author":"Prestera","year":"1995","journal-title":"Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 Represses Nuclear Activation of Antioxidant Responsive Elements by Nrf2 Through Binding to the Amino-Terminal Neh2 Domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes Through Antioxidant Response Elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Izumi, Y., and Koyama, Y. (2024). Nrf2-Independent Anti-Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases. Antioxidants, 13.","DOI":"10.3390\/antiox13121527"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Thomas, S.D., Jha, N.K., Sadek, B., and Ojha, S. (2022). Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise. Pharmaceuticals, 15.","DOI":"10.3390\/ph15050497"},{"key":"ref_46","first-page":"2","article-title":"Dimethyl Fumarate in Psoriasis Therapy","volume":"7","author":"Weisenseel","year":"2019","journal-title":"EMJ Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/IJN.S481917","article-title":"Hyaluronic Acid-Based Hybrid Nanoparticles as Promising Carriers for the Intranasal Administration of Dimethyl Fumarate","volume":"20","author":"Serri","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"104500","DOI":"10.1016\/j.msard.2023.104500","article-title":"Comparative Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam\u00ae (Monomethyl Fumarate) vs. Vumerity\u00ae (Diroximel Fumarate)","volume":"70","author":"Rousseau","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_49","unstructured":"European Medicines Agency Riulvy (2025, November 08). European Medicines Agency. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/riulvy."},{"key":"ref_50","first-page":"53","article-title":"Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-Blind, Placebo-Controlled AFFIRM Study","volume":"15","author":"Mrowietz","year":"2022","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/2211-5463.13969","article-title":"Comparative Activity of Dimethyl Fumarate Derivative IDMF in Three Models Relevant to Multiple Sclerosis and Psoriasis","volume":"15","author":"He","year":"2025","journal-title":"FEBS Open Bio"},{"key":"ref_52","unstructured":"Biogen GmbH (2024). Einstellung der Produktion und des Vertriebs von Fumaderm\u00ae Initial Und Fumaderm\u00ae, Biogen. Available online: https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Zulassung\/amInformationen\/Lieferengpaesse\/info_Dimethylfumarat_Ethylhydrogenfumarat_10241206.pdf?__blob=publicationFile."},{"key":"ref_53","unstructured":"Biogen GmbH (2020). Fumaderm\u00ae Initial Fumaderm\u00ae, Biogen. Available online: https:\/\/www.biogen.de\/content\/dam\/corporate\/europe\/germany\/de-de\/medicines\/Fumaderm-Fachinfo.pdf."},{"key":"ref_54","unstructured":"European Medicines Agency (2022). Skilarence, INN-Dimethyl Fumarate, EMA. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/skilarence-epar-product-information_en.pdf."},{"key":"ref_55","unstructured":"European Medicines Agency (2021). Vumerity, INN-Diroximel Fumarate, EMA. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vumerity-epar-product-information_en.pdf."},{"key":"ref_56","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research (2025, November 13). VUMERITY\u00ae (Diroximel Fumarate), Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211855s000lbl.pdf."},{"key":"ref_57","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research (2025, November 13). BAFIERTAM\u00ae (Monomethyl Fumarate), Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/210296s000lbl.pdf."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-021-00799-9","article-title":"Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of BafiertamTM (Monomethyl Fumarate) or Tecfidera\u00ae (Dimethyl Fumarate)","volume":"35","author":"Lategan","year":"2021","journal-title":"CNS Drugs"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.toxlet.2021.07.005","article-title":"Human Variability in Carboxylesterases and Carboxylesterase-Related Uncertainty Factors for Chemical Risk Assessment","volume":"350","author":"Darney","year":"2021","journal-title":"Toxicol. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2015.04.006","article-title":"DMF, but Not Other Fumarates, Inhibits NF-\u03baB Activity in Vitro in an Nrf2-Independent Manner","volume":"283","author":"Gillard","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric Acid Esters Exert Neuroprotective Effects in Neuroinflammation via Activation of the Nrf2 Antioxidant Pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuint.2010.01.006","article-title":"Fumaric Acid Diesters Deprive Cultured Primary Astrocytes Rapidly of Glutathione","volume":"57","author":"Schmidt","year":"2010","journal-title":"Neurochem. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1039\/C6AY01991A","article-title":"LC-MS\/MS Quantification of Dimethyl Fumarate and Methyl Hydrogen Fumarate in Rat Blood Using Tiopronin as Trapping Reagent","volume":"8","author":"Junnotula","year":"2016","journal-title":"Anal. Methods"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.jid.5700686","article-title":"Dimethylfumarate Induces Immunosuppression via Glutathione Depletion and Subsequent Induction of Heme Oxygenase 1","volume":"127","author":"Lehmann","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kluknavsky, M., Balis, P., Liskova, S., Micurova, A., Skratek, M., Manka, J., and Bernatova, I. (2024). Dimethyl Fumarate Prevents the Development of Chronic Social Stress-Induced Hypertension in Borderline Hypertensive Rats. Antioxidants, 13.","DOI":"10.3390\/antiox13080947"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/PTT.S51490","article-title":"Fumaric Acid Esters in the Management of Psoriasis","volume":"5","author":"Balak","year":"2015","journal-title":"Psoriasis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","article-title":"Fumarates Promote Cytoprotection of Central Nervous System Cells Against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway","volume":"341","author":"Scannevin","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/1523-1747.ep12358715","article-title":"Effects of Monomethylfumarate on Human Granulocytes","volume":"101","author":"Nibbering","year":"1993","journal-title":"J. Investig. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000237615","article-title":"Modulation of Protective and Pathological Immunity in Mycobacterial Infections","volume":"113","author":"Ottenhoff","year":"1997","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00403-010-1061-4","article-title":"Pharmacokinetics of Anti-Psoriatic Fumaric Acid Esters in Psoriasis Patients","volume":"302","author":"Clement","year":"2010","journal-title":"Arch. Dermatol. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2125.2004.02145.x","article-title":"Pharmacokinetics of Oral Fumarates in Healthy Subjects","volume":"58","author":"Litjens","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/1060028013509232","article-title":"Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis","volume":"47","author":"Venci","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2017.11.002","article-title":"The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects","volume":"39","author":"Mrowietz","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/00498254.2023.2217506","article-title":"Metabolism, Pharmacokinetics and Excretion of [14C]Dimethyl Fumarate in Healthy Volunteers: An Example of Xenobiotic Biotransformation Following Endogenous Metabolic Pathways","volume":"53","author":"Xu","year":"2023","journal-title":"Xenobiotica"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00726-013-1568-z","article-title":"Adipocyte Protein Modification by Krebs Cycle Intermediates and Fumarate Ester-Derived Succination","volume":"45","author":"Manuel","year":"2013","journal-title":"Amino Acids"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1523-1747.2003.12605.x","article-title":"Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells","volume":"121","author":"Treumer","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lima, A.D.R., Ferrari, B.B., Pradella, F., Carvalho, R.M., Rivero, S.L.S., Quintiliano, R.P.S., Souza, M.A., Brunetti, N.S., Marques, A.M., and Santos, I.P. (2024). Dimethyl Fumarate Modulates the Regulatory T Cell Response in the Mesenteric Lymph Nodes of Mice with Experimental Autoimmune Encephalomyelitis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1391949"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/jid.2008.197","article-title":"Detection of Metabolites of Fumaric Acid Esters in Human Urine: Implications for Their Mode of Action","volume":"129","author":"Clement","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"107710","DOI":"10.1016\/j.pharmthera.2020.107710","article-title":"Dimethyl Fumarate Induced Lymphopenia in Multiple Sclerosis: A Review of the Literature","volume":"219","author":"Scott","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Jadeja, R.N., Powell, F.L., Martin, P.M., Jadeja, R.N., Powell, F.L., and Martin, P.M. (2020). Repurposing Fumaric Acid Esters to Treat Conditions of Oxidative Stress and Inflammation: A Promising Emerging Approach with Broad Potential. Drug Repurposing\u2014Hypothesis, Molecular Aspects and Therapeutic Applications, IntechOpen.","DOI":"10.5772\/intechopen.91915"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF01300748","article-title":"Gastric Emptying of Indigestible Tablets in Relation to Composition and Time of Ingestion of Meals Studied by Metal Detector","volume":"36","author":"Ewe","year":"1991","journal-title":"Dig. Dis. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jssc.202001007","article-title":"Stability Indicating RP-HPLC Method for Determination of Dimethyl Fumarate in Presence of Its Main Degradation Products: Application to Degradation Kinetics","volume":"44","author":"Habib","year":"2021","journal-title":"J. Sep. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.22159\/ijap.2017v9i5.20944","article-title":"Stability Indicating RP-HPLC Assay Method for Estimation of Dimethyl Fumarate in Bulk and Capsules","volume":"9","author":"Jain","year":"2017","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/nure.12027","article-title":"Ethanol Metabolism and Its Effects on the Intestinal Epithelial Barrier","volume":"71","author":"Elamin","year":"2013","journal-title":"Nutr. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0016-5085(19)32262-0","article-title":"Aspirin Esterase of Gastric Mucosal Origin","volume":"73","author":"Builder","year":"1977","journal-title":"Gastroenterology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000171159","article-title":"Effects of Ethanol on the Gastric Mucosa","volume":"5","author":"Guslandi","year":"1987","journal-title":"Dig. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1756285614564152","article-title":"Dimethyl Fumarate in the Treatment of Relapsing\u2013Remitting Multiple Sclerosis: An Overview","volume":"8","author":"Bomprezzi","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40120-019-0127-2","article-title":"Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes","volume":"8","author":"Min","year":"2019","journal-title":"Neurol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Poitras, P., Bilodeau, M., Bouin, M., and Ghia, J.-E. (2022). The Pancreas. The Digestive System: From Basic Sciences to Clinical Practice, Springer International Publishing.","DOI":"10.1007\/978-3-030-98381-9"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00424-005-1487-2","article-title":"Molecular Properties of the SLC13 Family of Dicarboxylate and Sulfate Transporters","volume":"451","author":"Pajor","year":"2006","journal-title":"Pfl\u00fcg. Arch."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Liu, S., Qiu, Y., Gu, F., Xu, X., Wu, S., Jin, Z., Wang, L., Gao, K., Zhu, C., and Yang, X. (2022). Niacin Improves Intestinal Health through Up-Regulation of AQPs Expression Induced by GPR109A. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158332"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Xu, R.-C., Miao, W.-T., Xu, J.-Y., Xu, W.-X., Liu, M.-R., Ding, S.-T., Jian, Y.-X., Lei, Y.-H., Yan, N., and Liu, H.-D. (2022). Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment Through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice. Nutrients, 14.","DOI":"10.3390\/nu14194163"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12017-025-08883-9","article-title":"The Role of Gut Microbiota in Modulating Immune Signaling Pathways in Autoimmune Diseases","volume":"27","author":"Younis","year":"2025","journal-title":"NeuroMol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138920010794328904","article-title":"The Role of Intestinal Carboxylesterase in the Oral Absorption of Prodrugs","volume":"11","author":"Imai","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1039\/D1MD00073J","article-title":"Human Carboxylesterases and Fluorescent Probes to Image Their Activity in Live Cells","volume":"12","author":"Singh","year":"2021","journal-title":"RSC Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human Carboxylesterases: A Comprehensive Review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/092986609789071324","article-title":"Human Carboxylesterases: An Update on CES1, CES2 and CES3","volume":"16","author":"Sanghani","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jmb.2006.08.025","article-title":"Multisite Promiscuity in the Processing of Endogenous Substrates by Human Carboxylesterase 1","volume":"363","author":"Bencharit","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","article-title":"Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine","volume":"34","author":"Imai","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Ribone, S.R., Estrin, D.A., and Quevedo, M.A. (2025). Exploring Human Carboxylesterases 1 and 2 Selectivity of Two Families of Substrates at an Atomistic Level. Biochim. Biophys. Acta BBA Proteins Proteom., 1873.","DOI":"10.1016\/j.bbapap.2025.141069"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1124\/dmd.105.004226","article-title":"Identification of Esterases Expressed in Caco-2 Cells and Effects of Their Hydrolyzing Activity in Predicting Human Intestinal Absorption","volume":"33","author":"Imai","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1124\/dmd.116.072736","article-title":"Establishment and Characterization of a Novel Caco-2 Subclone with a Similar Low Expression Level of Human Carboxylesterase 1 to Human Small Intestine","volume":"44","author":"Ohura","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/978-3-540-69828-9_12","article-title":"Bgee: Integrating and Comparing Heterogeneous Transcriptome Data Among Species","volume":"Volume 5109","author":"Bairoch","year":"2008","journal-title":"Data Integration in the Life Sciences"},{"key":"ref_105","unstructured":"(2025, October 22). CES1-ENSSSCG00000039985. Available online: https:\/\/www.bgee.org\/gene\/ENSSSCG00000039985."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"100040","DOI":"10.1016\/j.xjidi.2021.100040","article-title":"A Sensitization-Free Dimethyl Fumarate Prodrug, Isosorbide Di-(Methyl Fumarate), Provides a Topical Treatment Candidate for Psoriasis","volume":"1","author":"Bojanowski","year":"2021","journal-title":"JID Innov."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1248\/bpb.30.532","article-title":"Stereoselective Characteristics and Mechanisms of Epidermal Carboxylesterase Metabolism Observed in HaCaT Keratinocytes","volume":"30","author":"Zhu","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, Paraoxonase, and Albumin Esterase, but Not Carboxylesterase, Are Present in Human Plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpha.2020.05.006","article-title":"Rapid Bioluminescence Assay for Monitoring Rat CES1 Activity and Its Alteration by Traditional Chinese Medicines","volume":"10","author":"Zhang","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1046\/j.1432-1033.2002.03121.x","article-title":"Identification of Microsomal Rat Liver Carboxylesterases and Their Activity with Retinyl Palmitate","volume":"269","author":"Sanghani","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/pmic.200900105","article-title":"Human Plasma Carboxylesterase 1, a Novel Serologic Biomarker Candidate for Hepatocellular Carcinoma","volume":"9","author":"Na","year":"2009","journal-title":"Proteomics"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/cpt.2486","article-title":"Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism","volume":"111","author":"Shi","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_113","unstructured":"(2025, October 22). CES1-ENSG00000198848. Available online: https:\/\/www.bgee.org\/gene\/ENSG00000198848."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1074\/mcp.RA118.000922","article-title":"Identification of Novel Protein Targets of Dimethyl Fumarate Modification in Neurons and Astrocytes Reveals Actions Independent of Nrf2 Stabilization","volume":"18","author":"Piroli","year":"2019","journal-title":"Mol. Cell. Proteom."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1111\/bph.13184","article-title":"Dimethyl Fumarate Induces Necroptosis in Colon Cancer Cells through GSH Depletion\/ROS Increase\/MAPKs Activation Pathway","volume":"172","author":"Xie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.5958\/0974-360X.2020.00529.6","article-title":"An Overview of DRF in the Treatment of Multiple Sclerosis","volume":"13","author":"Varshney","year":"2020","journal-title":"Res. J. Pharm. Technol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40120-019-00174-3","article-title":"A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing\u2013Remitting Multiple Sclerosis","volume":"9","author":"Allan","year":"2020","journal-title":"Neurol. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1177\/13524585231205708","article-title":"Diroximel Fumarate in Patients with Relapsing\u2013Remitting Multiple Sclerosis: Final Safety and Efficacy Results from the Phase 3 EVOLVE-MS-1 Study","volume":"29","author":"Singer","year":"2023","journal-title":"Mult. Scler. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjd.15839","article-title":"Dimethyl Fumarate Modulates Neutrophil Extracellular Trap Formation in a Glutathione- and Superoxide-dependent Manner","volume":"178","author":"Hoffmann","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1152\/physrev.00034.2014","article-title":"Metabolic Methanol: Molecular Pathways and Physiological Roles","volume":"95","author":"Dorokhov","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Hovda, K.E., McMartin, K., and Jacobsen, D. (2017). Methanol and Formaldehyde. Critical Care Toxicology, Springer.","DOI":"10.1007\/978-3-319-17900-1_78"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/713857189","article-title":"Toxicological and Metabolic Consequences of Methanol Poisoning","volume":"13","author":"Skrzydlewska","year":"2003","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_123","unstructured":"(2025, October 22). ADH5-ENSG00000197894. Available online: https:\/\/www.bgee.org\/gene\/ENSG00000197894."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/13524585251316518","article-title":"Severe Gastrointestinal Adverse Reactions Including Perforation, Ulceration, Hemorrhage, and Obstruction: A Fumaric Acid Ester Class New Safety Risk","volume":"31","author":"Kim","year":"2025","journal-title":"Mult. Scler. J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1186\/s12967-024-05507-x","article-title":"Uncovering Newly Identified Aldehyde Dehydrogenase 2 Genetic Variants That Lead to Acetaldehyde Accumulation After an Alcohol Challenge","volume":"22","author":"Rwere","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0536.1985.tb01073.x","article-title":"Ethnic Contact Urticaria to Alcohol","volume":"12","author":"Wilkin","year":"1985","journal-title":"Contact Dermat."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0140-6736(81)91172-7","article-title":"Aldehyde Dehydrogenase Deficiency as Cause of Facial Flushing Reaction to Alcohol in Japanese","volume":"318","author":"Harada","year":"1981","journal-title":"Lancet"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1039\/D4SC01183J","article-title":"A Mitochondrial-Targeted Activity-Based Sensing Probe for Ratiometric Imaging of Formaldehyde Reveals Key Regulators of the Mitochondrial One-Carbon Pool","volume":"15","author":"Tenney","year":"2024","journal-title":"Chem. Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jama.1966.03110120147042","article-title":"Extracorporeal Dialysis for Methanol Intoxication","volume":"197","author":"Pfister","year":"1966","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40263-021-00830-z","article-title":"Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use","volume":"35","author":"Paik","year":"2021","journal-title":"CNS Drugs"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41419-025-07412-7","article-title":"Dimethyl Fumarate Promotes the Degradation of HNF1B and Suppresses the Progression of Clear Cell Renal Cell Carcinoma","volume":"16","author":"Dai","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Camelo, S. (2025). Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136112"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1523-1747.2001.00211.x","article-title":"Dimethylfumarate Is an Inhibitor of Cytokine-Induced Nuclear Translocation of NF-Kappa B1, but Not RelA in Normal Human Dermal Fibroblast Cells","volume":"116","author":"Vandermeeren","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/med.21567","article-title":"Dimethyl Fumarate, a Two-Edged Drug: Current Status and Future Directions","volume":"39","author":"Saidu","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Dwivedi, D.K., Jena, G., and Kumar, V. (2020). Dimethyl Fumarate Protects Thioacetamide-Induced Liver Damage in Rats: Studies on Nrf2, NLRP3, and NF-\u03baB. J. Biochem. Mol. Toxicol., 34.","DOI":"10.1002\/jbt.22476"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuro.2022.06.003","article-title":"Gasdermin D-Mediated Microglial Pyroptosis Exacerbates Neurotoxicity of Aflatoxins B1 and M1 in Mouse Primary Microglia and Neuronal Cultures","volume":"91","author":"Zhang","year":"2022","journal-title":"NeuroToxicology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imr.13294","article-title":"Pyroptosis in Glioma: Current Management and Future Application","volume":"321","author":"Guo","year":"2024","journal-title":"Immunol. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 Inflammasome in Neuroinflammation and Central Nervous System Diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Elbaz, E.M., Abdel Rahman, A.A.S., El-Gazar, A.A., and Ali, B.M. (2024). Protective Effect of Dimethyl Fumarate Against Ethanol-Provoked Gastric Ulcers in Rats via Regulation of HMGB1\/TLR4\/NF-\u03baB, and PPAR\u03b3\/SIRT1\/Nrf2 Pathways: Involvement of miR-34a-5p. Arch. Biochem. Biophys., 759.","DOI":"10.1016\/j.abb.2024.110103"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10863-025-10068-9","article-title":"Dimethyl Fumarate Improves Sepsis-Induced Acute Lung Injury by Inhibiting STING-Mediated Ferroptosis","volume":"57","author":"Yu","year":"2025","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2504633","DOI":"10.1080\/0886022X.2025.2504633","article-title":"Dimethyl Fumarate Ameliorated Pyroptosis in Contrast-Induced Acute Renal Injury by Regulating Endoplasmic Reticulum Stress and JAK2-STAT3 Pathway","volume":"47","author":"An","year":"2025","journal-title":"Ren. Fail."},{"key":"ref_142","first-page":"443","article-title":"Drug Repurposing of Dimethyl Fumarate in Parkinson\u2019s Disease: A Promising Disease-Modifying Strategy","volume":"29","author":"Gardoni","year":"2025","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JAD-215074","article-title":"Dimethyl Fumarate Is a Potential Therapeutic Option for Alzheimer\u2019s Disease","volume":"85","author":"Sun","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Manai, F., Govoni, S., and Amadio, M. (2022). The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies. Cells, 11.","DOI":"10.3390\/cells11244061"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Martinez, A.N., Tortelote, G.G., Pascale, C.L., Ekanem, U.-O.I., Leite, A.P.d.O., McCormack, I.G., and Dumont, A.S. (2024). Dimethyl Fumarate Mediates Sustained Vascular Smooth Muscle Cell Remodeling in a Mouse Model of Cerebral Aneurysm. Antioxidants, 13.","DOI":"10.3390\/antiox13070773"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.medidd.2022.100142","article-title":"Repurposing Dimethyl Fumarate for Gastric Ulcer and Ulcerative Colitis: Evidence of Local Efficacy without Systemic Side Effect","volume":"16","author":"Patel","year":"2022","journal-title":"Med. Drug Discov."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Kourakis, S., Timpani, C.A., Bagaric, R.M., Qi, B., Ali, B.A., Boyer, R., Spiesberger, G., Kandhari, N., Yan, X., and Kuang, J. (2025). Repurposed Nrf2 Activator Dimethyl Fumarate Rescues Muscle Inflammation and Fibrosis in an Aggravated Mdx Mouse Model of Duchenne Muscular Dystrophy. Redox Biol., 84.","DOI":"10.1016\/j.redox.2025.103676"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s43032-025-01956-x","article-title":"Dimethyl Fumarate Improves Diabetic Erectile Dysfunction in Rats via Nrf2-Mediated Suppression of Penile Endothelial Oxidative Stress","volume":"32","author":"Engin","year":"2025","journal-title":"Reprod. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Cattani-Cavalieri, I., da Maia Valen\u00e7a, H., Moraes, J.A., Brito-Gitirana, L., Romana-Souza, B., Schmidt, M., and Valen\u00e7a, S.S. (2020). Dimethyl Fumarate Attenuates Lung Inflammation and Oxidative Stress Induced by Chronic Exposure to Diesel Exhaust Particles in Mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249658"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Stojanovic, B., Jovanovic, I., Dimitrijevic Stojanovic, M., Stojanovic, B.S., Kovacevic, V., Radosavljevic, I., Jovanovic, D., Miletic Kovacevic, M., Zornic, N., and Arsic, A.A. (2025). Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons. Antioxidants, 14.","DOI":"10.3390\/antiox14080987"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1038\/s44318-025-00464-7","article-title":"Oxygen Needs Sulfur, Sulfur Needs Oxygen: A Relationship of Interdependence","volume":"44","author":"Sekine","year":"2025","journal-title":"EMBO J."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc3278","article-title":"NRF2 and Cancer: The Good, the Bad and the Importance of Context","volume":"12","author":"Sporn","year":"2012","journal-title":"Nat. Rev. Cancer"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/12\/1506\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T09:14:49Z","timestamp":1763975689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/12\/1506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":152,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["pharmaceutics17121506"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17121506","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]}}}